Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications
As the world endures the coronavirus disease 2019 (COVID-19) pandemic, the conditions of 35 million vulnerable individuals struggling with substance use disorders (SUDs) worldwide have not received sufficient attention for their special health and medical needs. Many of these individuals are complic...
Main Authors: | Yufeng Wei, Rameen Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/7/155 |
Similar Items
-
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01) -
Substance use and substance use disorder, in relation to COVID-19: protocol for a scoping review
by: Navin Kumar, et al.
Published: (2021-02-01) -
Defusing COVID-19: Lessons Learned from a Century of Pandemics
by: Graciela Mujica, et al.
Published: (2020-11-01) -
Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic
by: Antonio Pereira
Published: (2020-04-01) -
The COVID-19 pandemic: a systematic review of the current evidence
by: R. Ghomi, et al.
Published: (2020-11-01)